Evolent Health, Inc.
corporate_fare Company Profile
Evolent Health, Inc. (NYSE:EVH) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 5 items for EVH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 7/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for EVH spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Evolent Health Q2 Revenue Jumps 47% on New Performance Suite Contracts, Raises Full-Year Outlook
- Evolent Health Q2 Revenue Jumps 47% to $652.5M, Raises 2026 Guidance, Sees 2027 Adjusted EBITDA ≥$150M
- Evolent Health Reports Strong Q1, Reduces Net Loss, Secures $200M+ Annual Revenue Contract
- Evolent Health Reports Massive Goodwill Impairment, 26.6% Revenue Drop, and Widened Net Loss to $579.4M in Annual Report
- Evolent Health Reports Massive Goodwill Impairment, Widened Losses, and Lower 2026 Profit Guidance
Financial Snapshot
Short Interest & Short Volume
5.81 days to coverFINRA reported short interest of 14,068,069 shares in EVH as of the September 15, 2026 settlement, a 9.1% decrease from the prior period — about 5.8 days to cover at its recent average daily volume. On October 2, 2026, 37.7% of EVH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.